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Abstract: Systemic inflammation induced by periodontitis is suggested to be the link between
periodontitis and cardiovascular disease. The aim of this work was to explore the oral microbiome in
periodontitis in relation to disease severity and systemic inflammation. The saliva and subgingival
microbiome from periodontal pocket samples of patients with severe (n = 12) and mild periodontitis
(n = 13) were analyzed using metagenomic shotgun sequencing. The taxa and pathways abundances
were quantified. The diversity was assessed and the abundances to phenotype associations were
performed using ANCOM and linear regression. A panel of inflammatory markers was measured in
blood and was associated with taxa abundance. The microbial diversity and species richness did not
differ between severe and mild periodontitis in either saliva or periodontal pockets. However, there
were significant differences in the microbial composition between severe and mild periodontitis in the
subgingival microbiome (i.e., pocket samples) and, in a lower grade, in saliva, and this is positively
associated with systemic inflammatory markers. The “red complex” and “cluster B” abundances in
periodontal pockets were strongly associated with inflammatory markers interleukin-6 and the white
blood cell count. Our data suggest that systemic inflammation in severe periodontitis may be driven
by the oral microbiome and may support the indirect (inflammatory) mechanism for the association
between periodontitis and cardiovascular disease.
Keywords: periodontitis; systemic inflammation; oral microbiome; cardiovascular disease
1. Introduction
Clinical research has identified an association between periodontal disease (PD) and
cardiovascular disease (CVD). The main suspected mechanisms driving this association are
infectious (direct effect) and inflammatory (indirect effect) [1,2]. The indirect mechanism
suggests that periodontal inflammation caused by oral bacteria induces the production
of inflammatory mediators in the systemic circulation. To date, the association between
the oral microbiome and systemic inflammation has not been extensively investigated. It
is unknown whether oral bacteria that may cause systemic inflammation are part of the
saliva, subgingival periodontal pocket communities, or both. Most periodontal studies
have been performed only on the subgingival microbiome and have yielded contradictory
results. For example, the subgingival bacterial burden of 11 species was not found to
be associated with white blood cell counts or C-reactive protein (CRP) [3]. However, in
another study [4], the phyla Firmicutes and TM 7, along with 18 other individual taxa,
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were positively associated with a systemic inflammatory score, whereas the established
periodontal pathogens from the “red complex” (i.e., Porphyromonas gingivalis, Tannerella
forsythia, and Treponema denticola) [5] were found not to be associated [4]. In addition,
current evidence for the correlation between the oral microbiota and systemic inflammation
comes indirectly from intervention studies that report a reduction in systemic inflammation
after periodontal therapy [6]. However, this correlation may not be directly related to the
oral microbiome.
To date, there are many studies that have focused on the oral microbiome in PD that
use metagenomic technologies highlighted in two recent reviews [7,8]. However, most of
these studies are based on 16S rRNA amplicon sequencing. While amplicon sequencing
amplifies and sequences a small region of the ribosomal sequence, metagenomic shotgun-
sequencing (MGS) enables the sequencing of entire genomes. Thus, MGS analyses provide
more information about the microbial community investigated, such as predictions of the
metabolic potential or a higher taxonomic resolution than 16S. To our knowledge, there are
limited studies on the oral microbiome in PD using MGS [9,10], and none have investigated
the possible association between the oral microbiome and systemic inflammation.
In view of all the above mentioned issues, the aim of our study is to comprehensively
explore the oral microbiome present in saliva and periodontal pockets (i.e., subgingival
microbiome) in patients with clinically diagnosed PD using MGS, and its relationship
with a measured panel of circulating inflammatory markers. In addition, we present a
targeted analysis focusing on known periodontal pathogens and oral bacteria described to
be present in human atherosclerotic plaques. Our data show distinguishable differences in
the composition of the subgingival microbiome (i.e., pocket samples) between severe and
mild PD. Such microbial differences are associated with systemic inflammatory markers,
suggesting the role of those taxa in promoting systemic inflammation.
2. Results
2.1. Study Participants
The patient cohort involved 13 mild PD and 12 severe PD patients. According to the
periodontal classification 2017 [11,12], there were 10 cases of Stage I PD and 3 cases of
gingivitis in the group with mild PD (n = 13). The severe PD group (n = 12) consisted of
9 cases of Stage III PD, 2 cases of Stage IV PD, and 1 case of Stage II PD. The demographic
characteristics of both groups are presented in Table 1. There were no significant differences
in the CVD risk factors, namely BMI, hypertension, and smoking status, between the
groups. There was a trend toward higher circulating concentrations of IL-6 and IL-1RA in
the patients with severe PD compared to the mild PD (p < 0.1), whereas circulating WBC
and hsCRP were similar between groups. In addition, periodontal inflammation, measured
as the [18F]FDG uptake in the periodontium on PET/CT scans, tended to be higher in the
group of severe PD (Table 1).
Table 1. Baseline characteristics. Demographics are reported as mean ± SD or (number of partic-
ipants). Circulating cytokines and chemokines are reported as median (IQR). One sample’sIL-6
concentration was under the detection limit of 0.70 pg/mL. Periodontal inflammation is reported
as mean ± SD. Demographics were compared using the independent samples T-test (continuous
normally distributed variables) and X2 test (categorical variables). Circulating cytokines, chemokines,
and periodontal inflammation were compared using one-way ANCOVA while accounting for partici-
pant age. ˆ: p < 0.10, *: p < 0.05, **: p < 0.01. PPD: probing pocket depth, WBC: white blood cell count,
SUV: standard uptake value of periodontal [18F] FDG-uptake on [18F]FDG PET/CT scan.
Demographics Mild PD (n = 13) Severe PD (n = 12)
DPSI, 0–4 3.0 ± 0.0 4.0 ± 0.1 **
Mean PPD, mm 3.8 ± 0.5 5.3 ± 1.2 **
Deepest PPD, mm 4.7 ± 0.8 6.6 ± 1.6 **
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Table 1. Cont.
Demographics Mild PD (n = 13) Severe PD (n = 12)
Age, years 56 ± 9 63 ± 6 *
Sex, % men (n) 62 (8) 25 (3)
BMI, kg/m2 25.1 ± 3.5 28.4 ± 7.0
Hypertension, % (n) 46 (6) 58 (7)
Current smoking, % (n) 15 (2) 8 (1)
Circulating inflammatory markers
WBC, 106/mL 5.8 [4.5–6.2] 5.7 [5.5–6.5]
IL-1Ra, pg/mL 177 [157–236] 254 [188–428] ˆ
IL-6, pg/mL 1.4 [1.0–1.8] 2.0 [1.7–3.0] ˆ
hsCRP, µg/mL 0.7 [0.3–1.7] 0.7 [0.6–1.2]
Periodontal inflammation
Periodontium, SUVmean 1.5 ± 0.2 1.7 ± 0.3 ˆ
Periodontium, SUVmax 3.6 ± 0.5 3.6 ± 0.8
2.2. Microbiome Signatures
The microbial composition and diversity of each community (i.e., saliva and subgingi-
val microbiome in periodontal pockets) were quantified on all taxonomic levels (i.e., from
phylum to species). Differences between saliva and periodontal pocket (also referred to
as pocket) communities were identified. Subsequently, the diversity and bacterial taxon-
omy were associated with disease severity (i.e., mild and severe PD). Bacterial metabolic
pathway abundances in saliva and pockets were compared between mild and severe PD.
Finally, bacteria and metabolic pathways associated with disease severity were studied for
relationships with the markers of systemic inflammation.
2.2.1. Composition of the Oral Microbiome and Its Association with PD Disease Severity
The microbial composition and functional profile were quantified in 37 samples, com-
prising both saliva and periodontal pockets, using a marker-based mapping approach. In
addition, 15 samples belonged to saliva (8 mild PD/7 severe PD) and 22 were pooled sub-
gingival samples from periodontal pockets (11 mild PD/11 severe PD) (Tables S2 and S3).
A total of 11 phyla, 91 genera, 235 species, and 340 microbial metabolic pathways were
detected in the saliva and pocket samples from all patients. The phylum level composition
of saliva and pocket samples was comparable between participants with mild and severe
PD (Figure 1A). Assessment of the bacterial composition of the most abundant species
showed Corynebacterium matruchotii to be significantly more abundant in pocket samples of
participants with mild PD compared to those with severe PD (Figure 1B).
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is shown as a Tukey’s boxplot. Samples where the taxa are absent are not shown in the distribution. Significant differences 117 
are marked with an asterisk*. 118 
2.2.2. Diversity of the Microbiome and Its Association With PD Disease Severity  119 
No significant difference in alpha-diversity (Kruskal–Wallis P = 0.81), which 120 
measures the species diversity within one sample estimated with the Shannon index, or 121 
species richness (Kruskal–Wallis P = 0.39) was found between mild and severe PD and 122 
tissue source (i.e., saliva or pockets) groups (Figure 2). Beta-diversity, an index for the 123 
species diversity between two samples, estimated using the Bray–Curtis dissimilarity in- 124 
dex, showed separation between the saliva and pocket samples in a hierarchical cluster 125 
Figure 1. Taxa composition of pocket and saliva samples in each clinical group at the top 10 phylum (A) and species (B),
in pocket (n = 22, 11 mild PD cases and 11 severe PD cases) and saliva (n = 15, 8 mild and 7 severe PD cases). Each dot
represents the log10 of the relative abundance of taxa in a sample. The distribution of the abundances per clinical group is
shown as a Tukey’s boxplot. Samples where the taxa are absent are not shown in the distribution. Significant differences are
marked with an asteri k *.
.2.2. i it f t i r i e a Its ssociation with PD Disease Severity
o significant difference in alpha-diversity (Kruskal–Wallis, p = 0.81), which measures
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richn s (Kruskal–Wallis, p = 0.39) was found between mild and severe PD and tissue
sourc (i.e., saliva or pockets) group (Figure 2). Beta-diversi y, an index for the species di-
versity between two samples, esti ated using th Bray–Curtis dissimilar ty index, showed
separation between he saliva a d pocket samples in a hierarchical cluster dendrogram
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and ordination plots (Figure 3A,B). In periodontal pockets, severe PD samples were shifted
from the mild PD samples (PERMANOVA 2000 permutations, p = 0.05) (Figure 3A). After
independently analyzing pocket and saliva samples, we observed the microbial compo-
sition in mild PD pockets to be significantly different compared to those in severe PD
(PERMANOVA 2000 permutations, p = 0.03). In saliva samples, there was no signifi-
cant difference in composition between mild and severe PD (PERMANOVA, p = 0.25)
(Figure 3C).
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We further analyzed the beta-diversity associations with different phenotype markers
via PERMANOVA (Figure 3C), showing significant associations of bacteria in periodontal
pockets with different markers of systemic inflammation.
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Figure 3. Phenotypic effect on the oral microbiome. (A) PCoA plot using the Bray–Curtis dissimilarity. The percentage of
the axis represents the amount of variance explained by the principal component (PERMANOVA, saliva clinical group,
p = 0.25, pocket clinical group, p = 0.03). (B) Dendrogram of hierarchical clustering based on Bray–Curtis dissimilarity. The
shape represents the location of the sample, while the color represents whether the group was with mild or severe PD.
(C) PERMANOVA-based variance explained from the microbiome bacterial species composition by different phenotypical
parameters of the participants. R2 and P-values were calculated by PERMANOVA while controlling for the read number.
An independent analysis was performed in pocket (grey) and saliva (red) samples. The factors found to have a p-value
below 0.05 are outlined in black and marked with an asterisk *.
2.2.3. Individual Taxa and etabolic Pathways Associated with Disease Severity
Next, we used ANCOM to identify taxa associated with periodont l disease (Table S4).
In saliva samples, we ide tified 11 s ecies present exclusiv ly in patients with severe PD,
yet in a low proportion of participants. Among them, the most abundant species were
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Parvimonas micra, Anaeroglobus germinatus, and Bulleida extructa, which have previously
been associated with different health conditions (Table 2).
Table 2. Oral bacteria previously reported in the literature to be associated with PD and CVD. W values provided by
ANCOM per bacterial community source (pocket/saliva) indicate the number of ratios that pass a significance threshold
for each species (see Methods). The direction of the effect size, assessed by a clr-normalized linear model, is indicated,
showing whether the species was more or less abundant in severe PD. The species filtered out due to low prevalence in the
population are indicated. ‘Structural 0’ indicates the absence of the taxa in one disease group due to putative biological
differences between the groups.













prevalence - Low prevalence -
Anaeroglobus
geminatus CVD-atherosclerosis/PD [13–16] 0 Increased Structural Increased
Bulleidia extructa progressive PD [17] 35 Increased Structural Increased
Capnocytophaga
gingivales CVD-blood lipid markers [4]/[15] 0 Decreased 0 Increased
Capnocytophaga




markers [15]/[17] 0 Decreased Structural Increased
Capnocytophaga
unclassified CVD-blood lipid markers [15] 112 Decreased 0 Increased
Catonella morbi CVD-blood lipidmarkers/PD [14,15] 2 Increased Low prevalence -
Eubacterium
brachy stable PD [4,16,18] 105 Increased 0 Increased
Eubacterium
infirmum progressive PD [17] 3 Increased 0 Increased
Filifactor alocis progressive PD [13,14,16,17] 0 Increased 0 Decreased
Olsenella uli progressive PD [17] 0 Increased Structural Increased










plaques/progressive PD [17]/[21] 0 Increased 0 Increased
Tannerella forsythia CVD-atheroscleroticplaques/PD [13,14] /[16,19] 0 Increased 0 Increased
Treponema
denticola PD [14,16,19] 0 Increased 0 Increased
Streptococcus CVD-HDL, ApoA1/PD [21,22] 0 Increased 0 Decreased
Neisseria CVD-negatively with HDL,ApoA1/PD [21,22] 0 Increased 0 Increased
Fusobacterium CVD-total cholesterol,LDL/PD [14]/[16,21] 0 Increased 0 Increased
In pocket samples, the abundances of Actinomyces johnsonii, Corynebacterium matru-
chotii, and Capnocytophaga unclassified were significantly lower in severe PD, whereas the
abundances of Porphyromonas endodontalis, Eubacterium brachy, and Eubacterium saphenum
were significantly higher (Table S4).
Furthermore, we expanded our abovementioned species-level analyses by also investi-
gating whether consistent bacterial strain differences exist between mild and severe PD. We
obtained within-species genetic distance data for only 26 species where at least 3 samples
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were available. From those, the majority included less than 10 samples. PERMANOVA anal-
ysis did not show significant associations between phylogenetic distance and either severity
or sample location. The only significant association, Human_endogenous_retrovirus_K, how-
ever, had only 1 mild-PD sample, which hampered a proper assessment of the existence of
a consistent phenomenon (Methods) (Table S5).
After comparing bacterial taxa differences, bacterial metabolic pathway abundances
in saliva and pockets were compared between the two groups (Table S6). In saliva samples,
there were no significant differences, while in pocket samples, 6 pathways were found in
significantly lower abundances in severe PD compared to mild PD. 5 of those were anabolic
pathways, carrying out the production of glutamate, heme, or the amino acids isoleucine
and valine. The final pathway was involved in the pyruvate fermentation.
In addition, individual taxa and pathways were studied in relation to the probing
pocket depths, which is a continuous variable that can be used as a proxy for disease
severity. Similar associations as with PD severity were identified (Tables S7 and S8).
2.2.4. Identification of Bacteria and Bacterial Clusters Previously Reported in the Literature
to Be Associated with PD and CVD
We tested whether certain groups of periodontal pathogens, known as the pathogenic
clusters driving microbial dysbiosis and inflammation in periodontitis, were more abun-
dant in individuals with severe PD than in those with mild PD. Additionally, we identified
and compared between PD groups a series of taxa that had been previously associated
with clinical PD, dyslipidemia, and atherosclerotic plaques (Table 2).
The “red complex” (i.e., Porphyromonas gingivalis, Tannerella forsythia, and Treponema
denticola) [5] was found significantly increased both in saliva (Wilcoxon test, p = 0.03) and
in pocket samples (Wilcoxon test, p = 8 × 10−3) of patients with severe PD (Figure 4A).
“Cluster A,” reported to be representative for a mild periodontitis phenotype [23] that
consists of the bacterial genera Campylobacter, Corynebacterium, Fusobacterium, Leptotrichia,
Tanerella and Saccaribacteria, was not found to be significantly different between the defined
PD severity levels in our study (Figure S1). “Cluster B,” reported to be higher with severe
PD, was found significantly more abundant in the periodontal pockets of the severe PD
group (Wilcoxon test, p = 0.02) (Figure S1). This cluster is represented by Porphyromonas
gingivalis, Tannerella forsythia, and Treponema denticola (i.e., red complex), in addition to
Filifactior alocis, Treponema spp., and Fretibacterium spp. [23].
Next, we focused on oral bacterial taxa that had been previously detected in hu-
man atherosclerotic plaques. The combined abundance of genera Propionibacterium and
Parvimonas was significantly higher in saliva (Wilcoxon test, p = 0.02) and pocket samples
(Wilcoxon test, p = 0.01) of the group with severe PD (Figure 4B).
Additionally, we identified other lineages of interest in CVD to be different between
patients with mild and severe PD. Anaeroglobus geminatus, the abundance in the oral cavity
of which was found to be associated with symptomatic atherosclerosis [15], was detected
only in the saliva of patients with severe PD. The same was observed for the key stone
pathogen Porphyromonas gingivalis.
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We explored whether bacteria and metabolic pathways more abundant in severe PD
were also associated with systemic inflammation (Tables S9 and S10). For this purpose,
we correlated using linear models both species and pathways that differed between mild
and severe PD in our study with the markers for systemic inflammation, and the uptake
of glucose in the periodontium as a measurement of periodontal tissue inflammation by
PET-CT scans (Figure S2). In saliva samples, the abundance of Porphyromonas gingivalis was
significantly associated with the uptake of glucose in the periodontium (F-test p = 3 × 10−3),
measured by PET-CT scans and expressed as SUVmean.
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shows the location where the sample was taken from. Significant differences are marked with an asterisk *.
In periodontal pockets, 7 significant associations were found. Corynebacterium matru-
choti was negatively associated with circulating inflammation markers IL-6, IL-1Ra, and
the leukocyte count (WBC). Eubacterium saphenum was positively correlated with WBC and
IL-1Ra. In addition, Eubacterium brachy and Porphyromonas endodontalis showed trends for
associations with IL-6, IL-1Ra, WBC, and the SUVmean of periodontium.
Next, we checked how bacterial clusters that were increased in patients with severe
PD were associated with the markers of systemic inflammation. The “red complex” was
significantly associated with IL-6 (F-test p = 0.01), IL-1Ra (F-test p = 0.02), and WBC (F-test
p = 0.03) in pocket samples, whereas, in saliva, no significant associations were found.
“Cluster B” in pocket samples was similarly associated with WBC (F-test p = 6 × 10−3),
IL-6 (F-test p = 5 × 10−4), and IL-1Ra (F-test p = 6 × 10−3). The cluster of Propionibacterium
propionicum, Parvimonas micra, and Parvimonas unclassified was only significantly correlated
with IL-1Ra in saliva (F-test p = 0.03).
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Oral bacteria reported in the literature to be present in high abundance in human
atherosclerotic plaques were not found to be associated with systemic inflammation in
pockets, while they were significantly associated with IL-1Ra (pg/mL) (F-test p = 0.02)
in saliva (Table S11). Additionally, we found three pathways in pocket samples, which
were negatively associated with severe PD that also showed negative associations with
the inflammation markers, namely, the alanine biosynthesis pathway, heme biosynthesis
pathway, and heme biosynthesis pathway from glutamate. All of them were negatively
correlated with WBC, IL-6 (only a nonsignificant trend in the heme biosynthesis pathways)
and IL-1Ra (Figure S2).
3. Discussion
To the best of our knowledge, this is the first metagenomic analysis of the oral mi-
crobiome of saliva and periodontal pockets in patients with PD in relation to systemic
inflammation. We found out that microbial diversity and species richness do not differ
between severe PD and mild PD in either saliva or periodontal pockets. However, there
were significant differences in the microbial composition between severe and mild PD
in the subgingival microbiome and, in a lower grade, in saliva, and this was positively
associated with systemic inflammatory markers.
We compared individuals with severe and mild PD, matched for known risk factors
of CVD (e.g., hypercholesterolemia, hypertension, smoking, and BMI), and we measured
circulating markers of inflammation. This allowed us to explore solely (i.e., eliminating
confounders) the effect of the oral microbiota on systemic inflammation. Moreover, we
studied the severity of PD defined according to the new classification of periodontal
conditions 2017 [12]. Although the groups of mild and severe PD were not homogenous,
our results provide insight into the microbiological profile and functionality of PD with
different stages of severity.
We found PD severity to be associated with beta- and not with alpha-diversity in
subgingival periodontal pocket samples. This is in accordance with another study that
used MGS and compared subgingival samples of stable PD, progressive PD, and healthy
patients [17]. Despite the different classification criteria for PD between both studies,
and the lack of a healthy group in our investigation, it appears that alpha-diversity can
be used as an indicator of microbial flux in a state of dysbiosis. As, in our study, both
groups have microbial dysbiosis as being diagnosed with PD, the absence of significant
alpha-diversity differences might be expected. Moreover, our findings support the current
concept that PD is associated with ecological shifts in community structures rather than
shifts in members of this microbial community [14]. Changes between disease status do
not necessarily result from the replacement of health-associated species, but from the rise
in new dominant species presented previously in low frequencies. This is in accordance
with our observations; for instance, in periodontal pockets Porphyromonas endodontalis,
Eubacterium saphenum, and Eubacterium branchy increased their abundance simultaneously
with PD severity. These bacteria, together with Filifactor alocis, were also associated with
the deepest probing pocket depths, which corroborates other studies [4,16–18,24] and
supports their recognition as newly identified periodontal pathogens [16]. Moreover,
Porphyromonas endodontalis, Eubacterium brachy, and Eubacterium saphenum were positively
associated with the markers of systemic inflammation. This requires special attention and
further investigation, especially because Porphyromonas endodontalis is known primarily
to be associated with endodontal infections [25], which also frequently occur in patients
without PD.
Interestingly, Corynebacterium matruchotii was negatively associated with severe PD,
as well as with the inflammatory markers. This finding, together with the knowledge that
Corynebacterium matruchotii is typical for healthy periodontal sites [16], suggests that it may
be a bacterium beneficial for periodontal and systemic health, or a marker of a healthy
microbial community.
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In saliva samples, the beta-diversity of the microbiome was not different between
the two PD groups. The small sample size might explain why we did not detect signif-
icant differences. However, an interesting observation was that oral bacteria that were
previously reported in human atherosclerotic plaques, such as Porphyromonas gingivalis
and Anaeroglobus germinates [15], were found present only in saliva of patients with severe
PD. For example, Anaeroglobus was detected in 3 out of 7 individuals with severe PD but
not in the group with mild PD. Furthermore, Porphyromonas gingivalis was significantly
associated with FDG-uptake in the periodontium, as measured by PET-CT scans, which
once again, supports its etiological key role in PD. These observations require further
investigation, especially how bacteria present in the saliva may enter the bloodstream and
become encapsulated in the atherosclerotic plaques.
It is known that pathogenic species do not usually play a role as a single pathogenic
entity [5], but that relationships among several species determine the pathogenic role of
the microbiota. Our results further support this theory. Both bacteria of the Socransky’s
“red complex” [5] and “cluster B” from Hong and co-workers [23] were found significantly
enriched in the saliva and pockets of patients with severe PD compared to individuals with
mild PD. Moreover, their abundance in subgingival plaque samples was also positively
associated with circulating markers of systemic inflammation (e.g., IL-6 and WBC). Our
findings suggest the important role of these bacteria not only for PD, but also in systemic
inflammatory diseases. It has been proposed that periodontal keystone pathogens may
play a role in the etiopathogenesis of diseases with chronic low-grade inflammation, such
as cardiovascular diseases [26].
To further explore the association between PD and CVD, we studied clusters reported
in the literature as isolated from atherosclerotic plaques. Genera Propionibacterium and
Parvimonas, detected exclusively in atheroma plaques [13], were significantly increased in
saliva and pockets in the group with severe PD. Interestingly, the combined abundance of
Propionibacterium propionicum, Parvimonas micra, and Parvimonas unclassified in saliva was
correlated with the marker IL-1Ra, which is an anti-inflammatory factor. Other oral bacte-
ria, detected in human atherosclerotic plaques in symptomatic and asymptomatic CVD
patients, such as Porphyromonadaceae, Bacteroidaceae, Micrococcaceae, Streptococcaceae [27],
Proteobacteria, Actinobacteria [28], Veilllonella, and Streptococcocus [21] appeared not to be
associated with systemic inflammation in our study. These bacteria belong to the commen-
sal microbiota, and some of them are overabundant (Proteobacteria and Actinobacteria) in
periodontal health [4].
Elaborating further on the role of bacteria for the pathogenesis of PD and associated
systemic chronic inflammatory diseases, the “infectious burden” (i.e., total pathogen bur-
den), comprising the aggregate number of pathogens infecting the individual, is considered
to have a stronger association with CVD than the exposure to a single microbiome [21].
Therefore, all sources of bacteria (e.g., gut microbiome) should be considered when such
an association is discussed [13,29]. The scope of the current study was only the oral micro-
biome. However, it could not be excluded that the gut microbiome of patients with severe
PD is different to those without and, thus, could affect the systemic inflammation.
MGS gave us the advantage to explore not only “who were present”, but also “what
they did” [30]. Examining bacterial metabolic pathways can provide greater insight into
functional differences between health (symbiotic) and a periodontitis (dysbiotic) profile. In
our study, both groups had a dysbiotic profile due to the presence of disease, whereas the
only difference was the severity of PD. This might explain the absence of big differences
between groups. In pockets, 3 pathways were negatively associated with severe PD, namely,
the alanine biosynthesis pathway, heme biosynthesis pathway, and heme biosynthesis
pathway from glutamate. This is in agreement with reports that the disease-associated
subgingival microbiome encodes more metabolic degradation processes than biosynthesis
does [9,10]. Additionally, the underrepresented microbial metabolic pathways in severe PD
showed negative associations with the inflammatory markers WBC and IL-6. It is known
that periodontal pathogens are proteolytic, amino-acid degrading, and require hemin
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for their growth. The decrease in glutamate concentration in crevicular fluid is reported
in PD [31]. Based on that and our findings, we may speculate that bacteria involved in
pathways for the biosynthesis of amino-acids and heme (proteogenic and hemogenic) are
beneficial for the absence of systemic inflammation. Other pathway differences related
with PD might be masked by the absence of a healthy control group.
Despite several limitations of our study, the small sample size, and the absence of
healthy controls (i.e., participants with periodontal health), we have been able to pinpoint
lineages and functional features involved in the pathophysiology of PD and associated with
systemic inflammation. Our observations add data supporting the indirect (inflammatory)
mechanism for the association between PD and CVD.
4. Materials and Methods
4.1. Study Participants
In this study, 25 participants (40–80 years) were recruited among patients of the
department of Dentistry, Radboud University Medical Center, The Netherlands. This study
was an exploratory study, and hence, no sample size calculation had been performed.
Exclusion criteria were previous CVD, auto-immune diseases (including diabetes mellitus),
chronic immunomodulatory drug use, kidney disease (MDRD < 45 mL/min), or liver
disease (ALAT > 135 U/L). In addition, patients were excluded with infection (>38.5 ◦C or
antibiotic treatment), hospital admission, or vaccination within 1 month prior to study entry.
The study protocol was approved by the Institutional Review Board Arnhem/Nijmegen,
the Netherlands, with number 2017.3431/NL 61840.091.17. Approval was granted on 10
November 2017. All participants gave written informed consent.
4.2. Clinical Periodontal Examination
The Dutch Periodontal Screening Index (DPSI) and probing pocket depths (PPD) were
recorded by an experienced periodontist [AP]. Subjects with DPSI scores of 0, 1, and 2
were classified as having no PD (category A), those with a DPSI score of 3 as having mild
PD (category B), and subjects with DPSI scores of 3+ and 4 as having severe PD (category
C) [32,33]. The presence of alveolar bone loss on paired bitewings, defined as a > 2 mm
distance between the cement–enamel junction and alveolar bone crest [34], was used to
confirm the clinical diagnosis. Participants with DPSI category C and alveolar bone loss
were assigned to the severe PD group. Subjects with DPSI category B with or without
minor radiographic alveolar bone loss were categorized in the mild PD group. Participants
of both groups were matched on shared risk factors for CVD such as age, sex, body mass
index (BMI), and smoking. The case definitions for PD severity according to the new
periodontal classification 2017 [11] were defined in both groups. In addition, the mean PPD
and deepest PPD (mm) were calculated and defined based on all measured and recorded
probing pockets depths.
4.3. Markers of Systemic Inflammation
Circulating cell counts in peripheral blood were measured by Sysmex analyser (Sys-
mex). Plasma high-sensitivity CRP (hsCRP) concentrations were obtained using an enzyme-
linked immunosorbent assay (ELISA, R&D). Circulating interleukin (IL)-1Ra, and IL-6
concentrations were measured using a SimplePlex cartridge on the Ella platform (Protein
Simple, San Jose, CA, USA).
4.4. Periodontal Tissue Inflammation on [18F] FDG PET and Low-Dose CT Scanning
After adhering to a 24 h low-carbohydrate diet and 6 h of fasting, participants un-
derwent 2’-deoxy-2’-[18F]fluoro-D-glucose positron emission tomography ([18F]FDG PET)
(Appendix A) with low-dose noncontrast-enhanced CT on a dedicated Siemens Biograph
40 mCT scanner (Siemens Healthineers, Erlangen, Germany). Analyses were performed
on reconstruction settings according to European guidelines [35] using Inveon Research
Workspace v4.2 software. See Supplementary Materials for details.
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Periodontal tissue inflammation was determined by the [18F] FDG-uptake in the left
and right periodontium of maxilla-to-mandible. The mean standardized uptake value
(SUVmean) was calculated after correction for weight and [18F] FDG-dose (MBq).
4.5. Demographic and Biomarker Comparison
Mild and severe PD patients were compared for continuous variables using an in-
dependent samples T-test (if normally distributed according to Shapiro–Wilk test) and
for categorical variables using a X2 test. For the circulating cytokines, chemokines, and
periodontal inflammation, one-way ANCOVA was conducted to control for age differences
between mild and severe PD. Beforehand, outliers were removed (if ±3 SD from Z-scores)
and, thereafter, log(10)-transformed. Missing values were not imputed. A two-sided
p-value < 0.05 was considered statistically significant.
4.6. Microbial Sample Collection
Samples for shotgun sequencing were collected between 2 and 5 pm, and before any
dental treatment had been performed. Participants were asked to refrain from coffee,
cheese, and chlorhexidine usage and stay sober 1 h before sample collection. A modified
protocol from Belstrøm et al. 2017 was used [36]. First, 2–5 mL stimulated saliva was
collected after 30 s of chewing on a parafilm. Next, subgingival plaque samples were taken
from the deepest PPD with bleeding using sterile paper points, as previously described [36].
We tried to choose standardized sites for collection of the subgingival microbiome. Samples
were directly stored on ice in sterile Powerbead Solution (Qiagen, Hilden, Germany).
Microbial analysis was performed on pooled subgingival samples (i.e., combining paper
points from each site in the same tube).
4.7. Metagenomic Shotgun Sequencing
Microbial DNA was extracted from saliva and pocket samples using DNeasy®
UltraClean® Microbial Kit (Qiagen, Hilden, Germany), according to the manufacturer’s
instructions. We performed automated isolation with Qiacube (Qiagen, Hilden, Germany),
also according to the manufacturer’s protocol. The DNA concentration was determined
using the Qubit DNA HS assay (Qiagen, Hilden, Germany), and the quality using Nan-
odrop technology. The DNA input for all samples was normalized, and libraries were
sequenced in a single run. Library preparation was performed using Shotgun Metagenomic
Sequencing with Illumina HiSeq sequencing by Novogene (Illumina, San Diego, CA, USA).
We extracted a mean of 19.7 million paired-end sequencing reads per sample (min-
imum of 15.1 × 106 to maximum of 28.8 × 106). FastQ files were preprocessed using
KneadData v0.5.1 with the Homo_sapiens_Bowtie2_v0.1 database for removal of human
reads (Table S1) and default settings. Microbial composition profiling was performed with
MetaPhlan2 v2.6.0 [37], and the functional profile of the microbial communities using
HUMAnN2 v0.11.1 [38]. HUMAnN2 maps reads to a reference panel of gene families from
the UniProt Reference Clusters [39] (UniRef90), which can be merged into pathways from
the MetaCyc pathway database [40,41].
4.8. Data Analysis and Statistics
Data analysis was performed using R v3.6.2. We performed the following analysis on
different taxonomic levels (species, genus, and phylum).
Within-sample diversity (alpha-diversity) was estimated as Shannon entropy (vegan
v2.5-6 [42]). Differences in diversity between clinical groups were tested using Dunn’s test.
We calculated the Bray–Curtis dissimilarity [43] matrix from the taxonomy abundance
using the vegan package. Principal components of the matrix were calculated using ape
v5.3 [44]. We performed several PERMANOVA (vegan package) in the dissimilarity matrix
(2000 permutations) to estimate the effect of disease status, PPDdeepest, PPDmean, IL-1Ra,
IL-6, hsCRP, and WBC on the microbial community, while accounting for sample origin
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(saliva/pocket) and the number of reads available after QC. Hierarchical clustering of
samples was performed based on the dissimilarity matrix.
Individual taxa differences (of taxa present in over 20% of samples in a minimal
mean relative abundance of 0.01%) between the mild and the severe PD groups were
examined independently in pocket and saliva samples using the ANCOM procedure [45],
as implemented in [46]. Structural zeros (i.e., the absence of a taxon due to the underlying
niche community) were assessed based on the total absence in one group but presence in
the other. We used the function feature_table_pre_process (out_cut = 0.05, zero_cut = 0.90),
for further removal of taxa considered as outliers or with low prevalence. Effect sizes are
calculated from a linear model using the taxa’s centered log-ratio transformation (clr) [47]
relative abundance as the dependent variable, and the severity group as the explanatory
variable. This corresponds to the difference of means of clr-transformed taxa abundance
among groups. We included a pseudo-count of half of the minimum nonzero value per
sample prior to clr transformation. Statistical significance in ANCOM was set as a threshold
of 0.1 of false discovery rate (FDR) [48]. ANCOM performs ratios between all taxa and
reports a statistic W representing the number of ratios in which the null hypothesis could be
rejected at the given statistical threshold. We concluded that a taxon had enough statistical
evidence of changing between the groups if: (1) the number of subhypotheses rejected (W)
was above 60% of the total number of ratios of that taxon, or (2) a taxon was found as a
structural zero. We repeated the same procedure using pathway relative abundance (over
20% of prevalence and 0.1% of mean relative abundance). The same process was applied to
correlate taxa and PPDdeepest/PPDmean.
Systemic inflammation markers, such as IL-6, IL-1Ra, WBC, and hsCRP, were corre-
lated with bacterial taxa and pathways that were found to be significantly associated with
PD. Correlations were performed independently in pocket and saliva samples. We used a
linear model, including the participant’s age as a covariate, the inflammatory marker as the
dependent variable, and the clr-transformed abundance metric as the covariate of interest.
4.9. Strain-Level Investigation
The genetic variability below the species level was examined using StrainPhlAn (as
part of MetaPhlAn v2.7.2) [49]. StrainPhlAn is a marker-based approach to perform phylo-
genetic analysis within metagenomic species. We used the aligned reads to MetaPhlAn’s
markers to reconstruct sample-specific markers that represent the most abundant strain
per metagenomic species (sample2markers.py, accessed on 9 April 2021). Then, we used
strainphlan.py to perform a multiple sequence alignment (MUSCLE v3.8.31) [50] and
phylogenetic reconstruction (RaxML v8.1.5 [51,52], using GTRCAT substitution model) in
91 StrainPhlAn-detected clades. StrainPhlAn could successfully build 26 clades. We then
created a phylogenetic distance matrix between samples in each of the available trees (ape
and cophenetic function) and used it to build a PCoA (ape) and perform PERMANOVA
(vegan). PERMANOVA tested whether disease severity was associated with the observed
phylogenetic distances between participants within taxa. If samples for both blood and
pocket sources were available, PERMANOVA included the tissue location as the covariate
and participant ID as the strata.
5. Conclusions
Microbial diversity and species richness do not differ between severe PD and mild
PD in either saliva or periodontal pockets. However, there are significant differences in
the microbial composition between severe and mild PD in the subgingival microbiome
(i.e., pocket samples) and, in a lower grade, in saliva, and this is positively associated with
systemic inflammatory markers. Our data suggest that systemic inflammation in severe
periodontitis may be driven by the oral microbiome and may support the indirect (inflam-
matory) mechanism for association between periodontitis and cardiovascular disease.
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Appendix A. Periodontal Tissue Inflammation on [18F]FDG PET and Low-Dose
CT Scanning
Participants underwent [18F]FDG PET with low-dose noncontrast-enhanced CT from
the skull base to the trochanter major on a dedicated Siemens Biograph 40 mCT scanner
(Siemens Healthineers, Erlangen, Germany). After adhering to a 24 h low-carbohydrate diet
and 6 h of fasting, ~2.1 MBq/kg [18F]FDG was administered intravenously, as described
previously [26]. Glucose concentrations were obtained (5.3 ± 0.5 mmol/L) after injection.
Before scanning, participants rested in the supine position for 2 h.
Images were reconstructed according to EARL protocols, using a TrueX algorithm
with point spread function (PSF) and time-of-flight (TOF) measurements, using 3 iterations,
21 subsets, a matrix size of 200 × 200 (pixel spacing of 4.07 mm), a full-width at half-
maximum (FWHM) of 3 mm, and 2 min of PET data. Postprocessing was performed using
a 3D Gaussian filter kernel, 3.0 mm, using the Inveon Research Workspace 4.2 (Preclinical
Solutions, Siemens Medical Solutions USA, Knoxville, TN, USA).
Periodontal [18F]FDG-uptake was determined in two volumes of interest (VOI) by
two independent operators [MPN, AP]: the left and right periodontal tissue. Anatomic
landmarks, the foramen mentale in the mandible and the sinus maxillaris in the upper
jaw, were used to identify the periodontal regions of interest (ROIs). Next, four ROIs
were drawn on the transversal slices (2 lower jaw and 2 upper jaw on each side) in the
molar/premolar area based on CT imaging. By auto-interpolation of the layers, the selected
ROI became the volume of interest (VOI). These regions of interest were evaluated using
the Inveon Research Workspace 4.2.
Operators that determined the VOIs/ROIs were blinded for all participants’ character-
istics (including control or patient). The standardized uptake value (SUV) was extracted
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from each ROI after correction for [18F]FDG dose (MBq) and bodyweight using the PyRa-
diomics toolbox [52]. The SUVs of left and right periodontal tissue ROIs were averaged.
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